Foundation President and CEO Testified Before Congress on Drug Research
| 1 min read

Robert J. Beall, Ph.D, president and CEO of the Cystic Fibrosis Foundation testified before the Small Business Committee of the U.S. House of Representatives today. He urged members of the committee to support research for rare diseases such as CF.

Specifically, Dr. Beall asked Congress to reauthorize the Small Business Innovation Research (SBIR) program, which provides grants to small biotech companies. And, he urged Congress to dedicate a portion of these grants for small companies interested in developing innovative drug research and development programs for CF and other rare diseases. Congress must reauthorize the SBIR program before it expires in September.

Share this article
Topics
About the CF Foundation | Public Policy | Research
Recent news
CF Foundation Reflects on Progress Toward Equity, Racial Justice, Diversity, and Inclusion
News | 4 min read
CF Foundation Invests Up to $3.5M in Gensaic for Novel Gene Delivery Method
News | 2 min read
CF Foundation Urges Vertex Pharmaceuticals to Reverse Consequential Decision on Copay Assistance
News | 3 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe